AllStar Health Brands Inc., (ALST) and TPT Global Tech Inc. (TPTW) Announce Expanding Partnership for the Sales & Marketing of QuikLAB Rapid Covid-19 Testing Lab Modules 8:01 AM ET 8/26/20 | Dow Jones Related Quotes
3:59 PM ET 8/25/20 Symbol Last % Chg ALST 0.24 0.00% Real time quote.
MIAMI, FL / ACCESSWIRE / August 26, 2020 / AllStar Health Brands Inc. (OTC PINK:ALST) a specialty pharmaceutical and nutritional supplements company and TPT Global Tech a technology and solutions company are pleased to announce signing a Non Exclusive Distribution Agreement for Canada and US to add to the existing Non-Exclusive Distribution Agreement for Mexico and other Latin American countries.
"We are very pleased to announce the expansion of our initial non-exclusive partnership agreement to now include Canada and the US. AllStar Health Brands' goal is to work with TPT Medtech for both the geographic expansion of the QuikLAB modules within the US and Canada and also offer the best testing technologies within the QuikLAB modules. Both companies have a shared vision to make one-stop, mass testing for Covid-19, a near-term reality in the Americas," stated Dr. Daniel Bagi, President of AllStar.
AllStar believes that given the high Covid-19 infection rates around the world, and the ability to set up the QuikLAB testing modules at almost any location, the QuikLAB option may be part of the solution in combating the effects of this pandemic.
The QuikLAB testing modules offer a fast, complete testing option, at a rapid throughput, - up to 50 tests/hour, using either the PCR or antibody tests or both currently available on the market. The goal is to provide results within minutes to a few short hours, so appropriate treatment or isolation protocols can be recommended based on the results of the testing."
AllStar plans to provide several options for FDA, EUA-approved rapid Covid-19 anti-body tests, and PCR tests for the TPT Medtech QuikLab modules.
About AllStar Health Brands Inc.:
AllStar Health Brands Inc. is a Nevada Corporation established in 2017, and headquartered in Miami, Florida. AllStar is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select products, including medical devices, nutritional supplements, over the counter remedies and medicines all across the Americas and Europe. AllStar's goal is to bring additional products to the market and provide new, innovative options for better health and wellbeing.
For more information, please contact Investor Relations at (305) 423 7028.
About TPT Global Tech Inc:
TPT Global Tech Inc. (TPTW), based in San Diego, California, is a technology-based company with divisions providing telecommunications, medical technology, and product distribution, media content for domestic and international syndication as well as technology solutions. TPT Global Tech offers Software as a Service (SaaS), Technology Platform as a Service (PAAS), Cloud-based Unified Communication as a Service (UCaaS). It offers carrier-grade performance and support for businesses over its private IP MPLS fiber and wireless network in the United States. TPT's cloud-based UCaaS services allow businesses of any size to enjoy all the latest voice, data, media, and collaboration features in today's global technology markets. TPT Global Tech also operates as a Master Distributor for Nationwide Mobile Virtual Network Operators (MVNO) and Independent Sales Organization (ISO) as a Master Distributor for Pre-Paid Cellphone services, Mobile phones Cellphone Accessories and Global Roaming Cellphones.
Safe Harbor Statement
Statements about the Company's future expectations and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.
The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words "anticipate," "estimate," "expect," "intend," "plans," "projects," and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties, and assumptions, including the risks and uncertainties, noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing, and general economic risks and uncertainties.
$nafs ...nice addition here! News out this morning...
Voycare Welcomes Fudan University's Xuan Zhou to Board of Directors 8:48 AM ET 8/27/20 | Dow Jones Related Quotes
3:52 PM ET 8/26/20 Symbol Last % Chg NAFS 0.01 0.00% Real time quote.
COVINA, CA / ACCESSWIRE / August 27, 2020 / North America Frac Sand, Inc. dba Voycare (OTC PINK:NAFS) ("NAFS", "Voycare" or "Company"), a telemedicine service provider and Chinese language digital health platform exclusively dedicated to women's health, is pleased to welcome Xuan Zhou of Fudan University to its Board of Directors. Zhou's appointment became effective August 24, 2020.
Mrs. Xuan Zhou is a clinical psychotherapist and teaches in the Master of Applied Psychology program in the School of Social Development and Public Policy at Fudan University, one of China's most prestigious public research universities located in Shanghai. She has worked for over eight years as a bilingual licensed counselor in California, New York and China; improving the lives of many trying to overcome emotional problems while experiencing different life challenges such as depression, anxiety, trauma and couples or family counseling.
"We are pleased to welcome Xuan Zhou to our Board of Directors," said Hong Chen, CEO of Voycare. "Her significant experience in China's rapidly growing mental health sector, coupled with her vast international network in the field of psychology will be an invaluable asset to our short and long-term strategic plans for the expansion of our business in this underserved space."
Zhou is a member of the Chinese Psychological Society, a 9,000-member strong academic organization promoting the field of psychology, and often referred to the Chinese equivalent of the American Psychological Association. She is currently in the process of receiving her global accreditation from the International Psychoanalytical Association in the U.K., founded by Sigmund Freud in 1910. Zhou is a graduateof New York University Steinhardt School of Culture, Education, and Human Development, having earned a Master of Arts Degree in Counseling for Mental Health and Wellness.
"As a clinician and educator, I'm excited to be a part of company leveraging technology to fill a void in the mental health needs of many women and their families in China and abroad," said Zhou. "Voycare has recognized a disconnect still exists for many women seeking help, and I look forward to participating in the development of these innovative technologies that can better the quality of life for many women."
The Company currently continues to conduct closed beta testing of its digital health platform prior its September debut and official entry into China's rapidly growing telemedicine industry. China's tele-health market size is 700 billion RMB or approximately $US100 billion by the end of 2020 according to according to Phoenix News Media.
For more information about Voycare, please visit, www.voycare.com or follow us on Twitter @nafsvoycare.
About Voycare
North America Frac Sand, Inc. (OTC PINK:NAFS) dba Voycare is a California based telemedicine service provider and Chinese language digital health platform exclusively dedicated to women's health in Asia, with the primary focus on China. Voycare is creating a new type of cross border health care experience for women by leveraging telehealth and the gig-economy, giving women a voice when making the right health care decision for themselves and their families. Voycare currently focuses on two important areas in women's health, Counseling and Fertility. Founded in 2019, Voycare has offices in Los Angeles and Shanghai.
Safe Harbor Statement
This news release contains certain forward-looking information. All information, other than information regarding historic fact that addresses activities, events or developments that the Company believes, expects or anticipates will or may occur in the future is forward-looking information. The forward-looking information contained in this news release reflects the current expectations, assumptions and/or beliefs of the Company based on information currently available to the Company. The forward-looking information contained in this news release is subject to a number of risks and uncertainties that may cause actual results or events to differ materially from current expectations. Any forward-looking information speaks only as of the date on which it is made and, except as may be required by applicable law, the Company disclaims any obligation to update or modify such forward-looking information, either because of new information, future events or for any other reason. Although the Company believes that the assumptions inherent in the forward-looking information are reasonable, forward-looking information is not a guarantee of future performance and accordingly undue reliance should not be put on such information due to the inherent uncertainty therein.
$ITOX UNBELIEVABLE AT THIS PRICE THE CALVARY IS COMING $ITOX .0129. 52 week high over 2,000% higher at 26 cents. ITOX could be my next 1,000%+ alert. Like my alert on PNNX from 0035 - 89 cents, HENC 0017- 47 cents, HMLA 0017 to 9 cents ALPP 006- 40 cents, SHMP 0068 to 98 cents all within the last 18 months. ALL THESE STOCKS WERE UNKNOWN. All overlooked even as I pointed extensive, elaborate DD, months later as they went viral people using what I pointed out MONTHS prior to push them.???????
ITOX is one such 10,000% plus percentage running GEM. I have so much to write about it but I'll keep this short and simple so as not to bore you.
This MICROSCOPIC float artificial intelligence tech company is UNKNOWN and the current environment of stay at home etc that comes with Coronavirus is perfect for ITOX in more ways than one. Not only due to its technology will be useful to create new methods of conferencing, etc but also to find a cure. A new consortium of top scientists will be able to use some of the world’s most advanced supercomputers to look for solutions.
CEO FORMER VICE PRESIDENT OF R&D for MEDTRONIC which trades at $99!! Just ran over 700% to .0229 from my alert at 0035 in 2 days, will break 3 cents on the next run. 2 million on the bid! Look at the management. These guys are big boys, brains in the artificial intelligence arena. All connections with M.I.T and Medtronic. Wont be down here for long. 52 week high 26 cents!!???????????
Some VERY interesting stuff;
“Year over Year (“YoY”) revenue growth for the nine months ended September 30, 2019, was 29.6% below the same period last year. These results are at the lower side of our YTD revenue goals, and due to a lag in capital raised to date, we expect our 2019 annual revenue growth to fall below our previously anticipated levels. Due to this shortfall in capital funds, we expect both final quarter and annual 2019 revenues to be flat versus 2018 levels. On a positive note, during the first three quarters of 2019, additional customers entered Non-Disclosure Agreements (“NDAs”), a critical first step in the customer development process. This quarter we signed an NDA with an additional potential customer, bringing the total number of potential new customers with NDAs to six: two Medical Device companies (one of which is a Fortune 500 company); one Pharma company (another Fortune 500 company); one Aerospace (also a Fortune 500 company); one Automotive (a multinational corporation, based in Europe); and a multinational infrastructure company based in Asia. Although we are pleased with the number of new customers under NDA, we expect fewer customers will place their first orders in 2019 than previously anticipated. This is due to delays in bringing on full time sales staff, caused by the shortfall in anticipated capital raise. Despite these headwinds, our confidence is buoyed by factors stated previously: The continuing impact of an experienced leadership team; execution from our technology team, especially in the area of Artificial Intelligence & Machine Learning (“AI & ML”); execution of contracts secured; and focus on high potential growth markets (specifically Biotech, Pharma, and Medical Device Operations). Furthermore, we expect our business will continue to benefit from the rapid growth of the Industrial Internet of Things (“IIoT”) market, and our unique value proposition to serve said rapidly growing market. Market research shows the worldwide IIoT market in 2017 was $92 billion USD and is projected to be $227 billion USD by 2021 (25% CAGR). Our edge computing open-source hardware and proprietary ML algorithms employ our minimally-invasive load monitoring (“MILM”) technology to simply gather data and gain insights to monitor & scope power, move from preventive to predictive maintenance, and even optimize development and manufacturing processes. This unique value proposition has been embraced by our customers, including a Fortune 500 Pharmaceutical Manufacturer. It is important to repeat that our year to date results were at the lower end of our revenue goals due to the lag in securing additional capital funding, which totaled $160,000 in Q3 of 2019 ($35,000 more than reported last quarter).
While 2019 YoY revenue is expected to be flat compared to 2018, we remain optimistic for 2020 revenue growth. This is due to the factors stated above that are now firmly in place: experienced leadership; savvy technological talent, operational execution excellence; and focus on new customers and expanded business with the current customer base. Combined with the continued rapid growth of the IIoT market and the anticipated continued infusion of additional capital funding, we believe that we remain on track for strong growth and performance in 2020.”
ITOX is here sitting at 0126 their Convertible notes are all 1000%+ higher than current price!
$ITOX: Guess what Tom Siebel is involved in ???????
News 
Market Data 
Discover 
